These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1909 related articles for article (PubMed ID: 31064233)

  • 21. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
    Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome.
    Yang JH; Chou CH; Yang WS; Ho HN; Yang YS; Chen MJ
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):686-92. PubMed ID: 26700986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study.
    Cai C; Lin M; Xu Y; Li X; Yang S; Zhang H
    BMC Med; 2016 Oct; 14(1):165. PubMed ID: 27772531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
    Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
    Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Müllerian Hormone Accelerates Pathological Process of Insulin Resistance in Polycystic Ovary Syndrome Patients.
    Li XJ; Wang H; Lu DY; Yu TT; Ullah K; Shi XY; Shen YH; Fei XY; Lin ZY; Huang HF; Lin XH
    Horm Metab Res; 2021 Aug; 53(8):504-511. PubMed ID: 34384107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries.
    Lefebvre T; Dumont A; Pigny P; Dewailly D
    Reprod Biomed Online; 2017 Sep; 35(3):325-330. PubMed ID: 28624344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome.
    Tokmak A; Kokanali D; Timur H; Kuntay Kokanali M; Yilmaz N
    Gynecol Endocrinol; 2016 Nov; 32(11):926-930. PubMed ID: 27275748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin Sensitivity Indices in Patients with Polycystic Ovary Syndrome with Different Body Mass Index Categories.
    Shahin L; Hyassat D; Batieha A; Khader Y; El-Khateeb M; Ajlouni K
    Curr Diabetes Rev; 2020; 16(5):483-489. PubMed ID: 31441729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of supervised aerobic training on the levels of anti-Mullerian hormone and adiposity measures in women with normo-ovulatory and polycystic ovary syndrome.
    Al-Eisa E; Gabr SA; Alghadir AH
    J Pak Med Assoc; 2017 Apr; 67(4):499-507. PubMed ID: 28420905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 96.